Skip to Main Content

Digoxin In Alcohol Associated Hepatitis

Conditions

Hepatitis | Diseases of the Digestive System - Liver

Phase Pilot

What is the purpose of this trial?

Acute alcohol associated hepatitis (also known as AlcHep) is an illness that results from alcohol consumption. Patients with the severe form of AlcHep have up to 40% mortality within 6 months after diagnosis. There are no approved drugs to treat AlcHep. Pre-clinical studies show that digoxin, a drug currently used in the treatment of heart failure and other heart conditions, can improve liver injury associated with alcohol use. The main goal of this study is to assess the feasibility of conducting a future large clinical trial with respect to patient recruitment, digoxin administration and dose adjustment in patients admitted to the hospital with severe AlcHep.

  • Trial with
    Yale University School of Medicine
  • Start Date
    10/12/2021
  • End Date
    02/28/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/03/2021
  • Study HIC
    #2000030659